tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

SUPN Stock Latest News

Sage Therapeutics cutting over 330 jobs, Boston Globe reports
The FlySage Therapeutics cutting over 330 jobs, Boston Globe reports
15d ago
SAGE
SUPN
Supernus Pharmaceuticals Holds Annual Stockholders Meeting
PremiumCompany Announcements
Supernus Pharmaceuticals Holds Annual Stockholders Meeting
29d ago
8K
SUPN
H.C. Wainwright sees potential competition for Sage from Biogen
PremiumThe Fly
H.C. Wainwright sees potential competition for Sage from Biogen
29d ago
BIIB
SAGE
Sage Therapeutics price target raised to $9 from $8 at Truist
PremiumThe Fly
Sage Therapeutics price target raised to $9 from $8 at Truist
29d ago
SAGE
SUPN
Sage Therapeutics price target raised to $8.50 from $8 at Canaccord
PremiumThe Fly
Sage Therapeutics price target raised to $8.50 from $8 at Canaccord
29d ago
BIIB
SAGE
Sage Therapeutics price target raised to $8.50 from $8 at Canaccord
PremiumThe FlySage Therapeutics price target raised to $8.50 from $8 at Canaccord
29d ago
BIIB
SAGE
Sarepta suspends Elevidys shipments, Supernus acquires Sage: Morning Buzz
Premium
The Fly
Sarepta suspends Elevidys shipments, Supernus acquires Sage: Morning Buzz
1M ago
BA
BMY
Morning Movers: Sage Therapeutics surges after deal to be acquired by Supernus
Premium
The Fly
Morning Movers: Sage Therapeutics surges after deal to be acquired by Supernus
1M ago
X
AMZN
Supernus Pharmaceuticals to Acquire Sage Therapeutics
PremiumCompany Announcements
Supernus Pharmaceuticals to Acquire Sage Therapeutics
1M ago
8K
SUPN
Supernus to acquire Sage Therapeutics for $8.50 per share in cash plus CVR
PremiumThe Fly
Supernus to acquire Sage Therapeutics for $8.50 per share in cash plus CVR
1M ago
BIIB
SAGE
Supernus to acquire Sage Therapeutics for $8.50 per share in cash plus CVR
PremiumThe Fly
Supernus to acquire Sage Therapeutics for $8.50 per share in cash plus CVR
1M ago
SAGE
SUPN
Supernus expands partnership with Jay Glazer in new content series
PremiumThe Fly
Supernus expands partnership with Jay Glazer in new content series
2M ago
SUPN
Supernus Pharmaceuticals Faces Patent Challenges for Qelbree
PremiumCompany AnnouncementsSupernus Pharmaceuticals Faces Patent Challenges for Qelbree
2M ago
8K
SUPN
Supernus announces Paragraph IV ANDA filings for Qelbree
Premium
The Fly
Supernus announces Paragraph IV ANDA filings for Qelbree
2M ago
SUPN
Supernus partners with Busy Philipps for new campaign
Premium
The Fly
Supernus partners with Busy Philipps for new campaign
2M ago
SUPN
Supernus Pharmaceuticals’ Earnings Call: Growth Amid Challenges
PremiumCompany Announcements
Supernus Pharmaceuticals’ Earnings Call: Growth Amid Challenges
2M ago
SUPN
Supernus Pharmaceuticals Reports Q1 2025 Earnings Growth
PremiumCompany Announcements
Supernus Pharmaceuticals Reports Q1 2025 Earnings Growth
2M ago
SUPN
Optimistic Growth Prospects for Supernus Pharmaceuticals Driven by Qelbree’s Market Potential
PremiumRatings
Optimistic Growth Prospects for Supernus Pharmaceuticals Driven by Qelbree’s Market Potential
2M ago
SUPN
Supernus reports Q1 EPS (21c) vs. 0c last year
PremiumThe Fly
Supernus reports Q1 EPS (21c) vs. 0c last year
2M ago
SUPN
SUPN Earnings this Week: How Will it Perform?
PremiumPre-EarningsSUPN Earnings this Week: How Will it Perform?
2M ago
SUPN
Promising Growth Prospects for Supernus Pharmaceuticals: Buy Rating Driven by Qelbree and Onapgo Market Opportunities
Premium
Ratings
Promising Growth Prospects for Supernus Pharmaceuticals: Buy Rating Driven by Qelbree and Onapgo Market Opportunities
4M ago
SUPN
Serina Therapeutics initiated with a Buy at JonesResearch
Premium
The Fly
Serina Therapeutics initiated with a Buy at JonesResearch
4M ago
SER
SUPN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >